{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:52:13Z","timestamp":1794369133343,"version":"4.9.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["surgjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.surg.2017.04.033","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T00:47:04Z","timestamp":1510188424000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Predictive relevance of programmed cell death protein 1 and tumor-infiltrating lymphocyte expression in papillary thyroid cancer"],"prefix":"10.1016","volume":"163","author":[{"given":"Marra J.","family":"Aghajani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"McCafferty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Niles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2017.04.033_bib0010","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3109\/0284186X.2011.602109","article-title":"Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer","volume":"50","author":"Ahn","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.surg.2017.04.033_bib0015","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/thy.2012.0466","article-title":"Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry","volume":"23","author":"Bychkov","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2017.04.033_bib0020","doi-asserted-by":"crossref","first-page":"E934","DOI":"10.1210\/jc.2011-3428","article-title":"Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer","volume":"97","author":"French","year":"2012","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.surg.2017.04.033_bib0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1758834014548188","article-title":"Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer","volume":"6","author":"Worden","year":"2014","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.surg.2017.04.033_bib0030","doi-asserted-by":"crossref","first-page":"32318","DOI":"10.18632\/oncotarget.8698","article-title":"Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants","volume":"7","author":"Chowdhury","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.surg.2017.04.033_bib0035","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1210\/jc.2015-4227","article-title":"Tumor-infiltrating T cells and the PD-1 checkpoint pathway in advanced differentiated and anaplastic thyroid cancer","volume":"101","author":"Bastman","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2017.04.033_bib0040","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int Immunol"},{"key":"10.1016\/j.surg.2017.04.033_bib0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.surg.2017.04.033_bib0050","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.2147\/OTT.S105862","article-title":"PD-L1 expression in human cancers and its association with clinical outcomes","volume":"9","author":"Wang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.surg.2017.04.033_bib0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.21037\/atm.2016.04.01","article-title":"Harnessing the immune system to improve cancer therapy","volume":"4","author":"Papaioannou","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.surg.2017.04.033_bib0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40425-015-0059-z","article-title":"The therapeutic promise of disrupting the PD-1\/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors","volume":"3","author":"Romano","year":"2015","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.surg.2017.04.033_bib0065","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ctrv.2015.11.001","article-title":"Predictive biomarkers in PD-1\/PD-L1 checkpoint blockade immunotherapy","volume":"41","author":"Meng","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.surg.2017.04.033_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.surg.2017.04.033_bib0075","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1074\/mcp.M700500-MCP200","article-title":"Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry","volume":"7","author":"Ralhan","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.surg.2017.04.033_bib0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2172-11-19","article-title":"Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients","volume":"11","author":"Deschoolmeester","year":"2010","journal-title":"BMC Immunol"},{"key":"10.1016\/j.surg.2017.04.033_bib0085","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.surg.2017.04.033_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/ERC-12-0313","article-title":"Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation","volume":"20","author":"Cunha","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.surg.2017.04.033_bib0095","first-page":"3421","article-title":"The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland","volume":"80","author":"Matsubayashi","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2017.04.033_bib0100","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2009-2564","article-title":"Tumor-associated lymphocytes and increased FoxP3(+) regulatory T cell frequency correlate with more aggressive papillary thyroid cancer","volume":"95","author":"French","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.surg.2017.04.033_bib0105","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2265.2012.04482.x","article-title":"Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma","volume":"77","author":"Cunha","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.surg.2017.04.033_bib0110","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2326-6066.CIR-13-0034","article-title":"PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival","volume":"1","author":"Lipson","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.surg.2017.04.033_bib0115","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1158\/1078-0432.CCR-13-2702","article-title":"In situ tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas","volume":"20","author":"Schalper","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.surg.2017.04.033_bib0120","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.surg.2017.04.033_bib0125","doi-asserted-by":"crossref","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.surg.2017.04.033_bib0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejca.2015.11.020","article-title":"Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy","volume":"55","author":"Tokito","year":"2016","journal-title":"Eur J Cancer"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606017305536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606017305536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T05:25:04Z","timestamp":1535261104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606017305536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0039606017305536"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2017.04.033","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive relevance of programmed cell death protein 1 and tumor-infiltrating lymphocyte expression in papillary thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2017.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}